Evolution of the Average Target: IMPACT Therapeutics, Inc

Evolution of the Target Price: IMPACT Therapeutics, Inc

Changes in Analyst Recommendations: IMPACT Therapeutics, Inc

132bd8d93c8e8bffd0aea7ba6a.WUk8TA7tU4ZDiTFMRgNbS0UEA29mProd-IsxCa6EfVI.bQMFBDncZ_d1uVkDfzYjMQw8blYoUNQkq-ZDQPzTKSANEGkNY6sr1BrjXg~431f857631292c7102d503e594344219

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- - - - +128.59%
+16.44%
+22.14%
+17.84%
+6.62%
+25.91%
+18.49%
+49.69%
+8.86%
+71.01%
Average +36.56%
Weighted average by Cap. +23.29%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
12.03CNY
Average target price
27.28CNY
Spread / Average Target
+126.79%
High Price Target
27.28CNY
Spread / Highest target
+126.79%
Low Price Target
27.28CNY
Spread / Lowest Target
+126.79%

Analyst Consensus Detail

Consensus revision (last 18 months)

  1. Stock Market
  2. Stocks
  3. 7630 Stock
  4. Consensus IMPACT Therapeutics, Inc